img

Global Multiplexed Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Multiplexed Diagnostics Market Research Report 2024

The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
According to MRAResearch’s new survey, global Multiplexed Diagnostics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multiplexed Diagnostics market research.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Multiplexed Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Segment by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays

Segment by Application


Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Multiplexed Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.2.4 Medium Density Multiplexed Assays (plex Below 500)
1.2.5 Low Density Multiplexed Assays (plex Below 5)
1.2.6 Next Generation Sequencing Assays
1.3 Market by Application
1.3.1 Global Multiplexed Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2018-2033)
2.2 Multiplexed Diagnostics Growth Trends by Region
2.2.1 Global Multiplexed Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Multiplexed Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Multiplexed Diagnostics Market Dynamics
2.3.1 Multiplexed Diagnostics Industry Trends
2.3.2 Multiplexed Diagnostics Market Drivers
2.3.3 Multiplexed Diagnostics Market Challenges
2.3.4 Multiplexed Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Revenue
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
3.4 Global Multiplexed Diagnostics Market Concentration Ratio
3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2022
3.5 Multiplexed Diagnostics Key Players Head office and Area Served
3.6 Key Players Multiplexed Diagnostics Product Solution and Service
3.7 Date of Enter into Multiplexed Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplexed Diagnostics Breakdown Data by Type
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2024-2033)
5 Multiplexed Diagnostics Breakdown Data by Application
5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2018-2033)
6.2 North America Multiplexed Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Multiplexed Diagnostics Market Size by Country (2018-2023)
6.4 North America Multiplexed Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2018-2033)
7.2 Europe Multiplexed Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Multiplexed Diagnostics Market Size by Country (2018-2023)
7.4 Europe Multiplexed Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplexed Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Multiplexed Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplexed Diagnostics Market Size (2018-2033)
9.2 Latin America Multiplexed Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Multiplexed Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Multiplexed Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplexed Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Multiplexed Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Multiplexed Diagnostics Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Multiplexed Diagnostics Introduction
11.3.4 BioMerieux Revenue in Multiplexed Diagnostics Business (2018-2023)
11.3.5 BioMerieux Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Multiplexed Diagnostics Business (2018-2023)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Multiplexed Diagnostics Introduction
11.5.4 Illumina Revenue in Multiplexed Diagnostics Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 Luminex
11.6.1 Luminex Company Detail
11.6.2 Luminex Business Overview
11.6.3 Luminex Multiplexed Diagnostics Introduction
11.6.4 Luminex Revenue in Multiplexed Diagnostics Business (2018-2023)
11.6.5 Luminex Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Multiplexed Diagnostics Introduction
11.7.4 Hologic Revenue in Multiplexed Diagnostics Business (2018-2023)
11.7.5 Hologic Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Introduction
11.8.4 Thermo Fisher Scientific Revenue in Multiplexed Diagnostics Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Detail
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
11.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2018-2023)
11.9.5 Siemens Healthineers Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
11.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2018-2023)
11.10.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Multiplexed Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Very High Density Multiplexed Assays (Above 10,000-plex)
Table 3. Key Players of High Density Multiplexed Assays (500 Below plex Below 10,000)
Table 4. Key Players of Medium Density Multiplexed Assays (plex Below 500)
Table 5. Key Players of Low Density Multiplexed Assays (plex Below 5)
Table 6. Key Players of Next Generation Sequencing Assays
Table 7. Global Multiplexed Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Multiplexed Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Multiplexed Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Multiplexed Diagnostics Market Share by Region (2018-2023)
Table 11. Global Multiplexed Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Multiplexed Diagnostics Market Share by Region (2024-2033)
Table 13. Multiplexed Diagnostics Market Trends
Table 14. Multiplexed Diagnostics Market Drivers
Table 15. Multiplexed Diagnostics Market Challenges
Table 16. Multiplexed Diagnostics Market Restraints
Table 17. Global Multiplexed Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Multiplexed Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2022)
Table 20. Ranking of Global Top Multiplexed Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Multiplexed Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiplexed Diagnostics Product Solution and Service
Table 24. Date of Enter into Multiplexed Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiplexed Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Multiplexed Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Multiplexed Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Multiplexed Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global Multiplexed Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Multiplexed Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global Multiplexed Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Multiplexed Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America Multiplexed Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Multiplexed Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Multiplexed Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Multiplexed Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Multiplexed Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Multiplexed Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Multiplexed Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Multiplexed Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Multiplexed Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Multiplexed Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Multiplexed Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Agilent Technologies Company Detail
Table 50. Agilent Technologies Business Overview
Table 51. Agilent Technologies Multiplexed Diagnostics Product
Table 52. Agilent Technologies Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Agilent Technologies Recent Development
Table 54. Bio-Rad Laboratories Company Detail
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Multiplexed Diagnostics Product
Table 57. Bio-Rad Laboratories Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Bio-Rad Laboratories Recent Development
Table 59. BioMerieux Company Detail
Table 60. BioMerieux Business Overview
Table 61. BioMerieux Multiplexed Diagnostics Product
Table 62. BioMerieux Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 63. BioMerieux Recent Development
Table 64. F. Hoffmann-La Roche Company Detail
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Multiplexed Diagnostics Product
Table 67. F. Hoffmann-La Roche Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Illumina Company Detail
Table 70. Illumina Business Overview
Table 71. Illumina Multiplexed Diagnostics Product
Table 72. Illumina Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Illumina Recent Development
Table 74. Luminex Company Detail
Table 75. Luminex Business Overview
Table 76. Luminex Multiplexed Diagnostics Product
Table 77. Luminex Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Luminex Recent Development
Table 79. Hologic Company Detail
Table 80. Hologic Business Overview
Table 81. Hologic Multiplexed Diagnostics Product
Table 82. Hologic Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 83. Hologic Recent Development
Table 84. Thermo Fisher Scientific Company Detail
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Multiplexed Diagnostics Product
Table 87. Thermo Fisher Scientific Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 88. Thermo Fisher Scientific Recent Development
Table 89. Siemens Healthineers Company Detail
Table 90. Siemens Healthineers Business Overview
Table 91. Siemens Healthineers Multiplexed Diagnostics Product
Table 92. Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Siemens Healthineers Recent Development
Table 94. Abbott Laboratories Company Detail
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Multiplexed Diagnostics Product
Table 97. Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Abbott Laboratories Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplexed Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Multiplexed Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Very High Density Multiplexed Assays (Above 10,000-plex) Features
Figure 4. High Density Multiplexed Assays (500 Below plex Below 10,000) Features
Figure 5. Medium Density Multiplexed Assays (plex Below 500) Features
Figure 6. Low Density Multiplexed Assays (plex Below 5) Features
Figure 7. Next Generation Sequencing Assays Features
Figure 8. Global Multiplexed Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Multiplexed Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Academic Research Institutes Case Studies
Figure 11. Hospital Case Studies
Figure 12. Pharmaceutical Companies Case Studies
Figure 13. Clinical Research Organizations Case Studies
Figure 14. Diagnostic Laboratories Case Studies
Figure 15. Multiplexed Diagnostics Report Years Considered
Figure 16. Global Multiplexed Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Multiplexed Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Multiplexed Diagnostics Market Share by Region: 2022 VS 2033
Figure 19. Global Multiplexed Diagnostics Market Share by Players in 2022
Figure 20. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Multiplexed Diagnostics Revenue in 2022
Figure 22. North America Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Multiplexed Diagnostics Market Share by Country (2018-2033)
Figure 24. United States Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Multiplexed Diagnostics Market Share by Country (2018-2033)
Figure 28. Germany Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Multiplexed Diagnostics Market Share by Region (2018-2033)
Figure 36. China Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Multiplexed Diagnostics Market Share by Country (2018-2033)
Figure 44. Mexico Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Multiplexed Diagnostics Market Share by Country (2018-2033)
Figure 48. Turkey Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Multiplexed Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 52. BioMerieux Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 54. Illumina Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 55. Luminex Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 56. Hologic Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 58. Siemens Healthineers Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 59. Abbott Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed